Results 211 to 220 of about 28,778 (289)

A multicenter performance evaluation of aztreonam-avibactam gradient diffusion susceptibility testing for <i>Enterobacterales</i>. [PDF]

J Clin Microbiol
Bui TI, Csiki-Fejer E, Prudhomme S, Bossy L, Hardy DJ, Wootton M, Zambardi G, Yarbrough ML.   +7 more
europepmc   +1 more source

Clinically Significant Carbapenemases in Gram-Negative Pathogens: Molecular Diversity and Advances in β-Lactamase Inhibitor Therapy. [PDF]

Antibiotics (Basel)
Grossman JM, Thompson DK.
europepmc   +1 more source

Clinical outcomes of carbapenem therapy in OXA-48-producing Enterobacterales infections: a French multicentre cohort, systematic review, and meta-analysis. [PDF]

Emerg Microbes Infect
Dortet L, Moreau C, Dinh A, Bonnin RA, Escaut L, Seguret M, Weber L, Figueiredo S, Pilmis B.   +8 more
europepmc   +1 more source

<i>In vitro</i> activity of the novel β-lactamase inhibitor nacubactam against a nationwide collection of carbapenem-resistant Enterobacterales in Japan. [PDF]

JAC Antimicrob Resist
Yanagihara K, Tateda K, Doi Y, Takahashi S, Ohge H, Itahashi K, Okade H, Mikamo H.   +7 more
europepmc   +1 more source

Evaluation of three variants of the carbapenem inactivation method for carbapenemase detection in <i>Enterobacterales</i> and description of the cCIM, supplemented with cloxacillin. [PDF]

JAC Antimicrob Resist
Abels J, Eisfeld J, Pienkoß J, Gatermann SG, Pfennigwerth N.   +4 more
europepmc   +1 more source

Predictive value of extra-rectal colonization and the <i>Giannella</i> risk score for subsequent carbapenem-resistant <i>Enterobacterales</i> infections in ICU patients: an Argentinean retrospective cohort study in a mixed KPC and NDM setting. [PDF]

Infect Prev Pract
Favier P, Suárez-Urquiza P, Raffo C, Torres D, Pinilla-Huayta F, Muñoz-Soto C, Ravelli M, Serio E, Kumar L, Johanna P, Primost I, Gallino MI, Pemán-García J, Valentín-Martín A, González-Barberá EM.   +14 more
europepmc   +1 more source

Diversity of third-generation cephalosporin-resistant enterobacterales from human and animal samples obtained in Owerri, Nigeria. [PDF]

BMC Infect Dis
Nsofor CM, Molokwu CC, Osuagwu KI, Loncaric I, Nsofor CA.   +4 more
europepmc   +1 more source

High prevalence of bla_NDM gene among a series of carbapenem-resistant Enterobacterales isolates from children less than one year old in Niger. [PDF]

BMC Microbiol
Massir IN, Abdourahamane Y, Ounoussa T, Oumou H, Abdoulaye O, Ousmane A, Harouna M, Souleymane B, Doutchi M, Saidou M, Laminou IM.   +10 more
europepmc   +1 more source

Multicenter Analytical Performance Evaluation of the BD Phoenix NMIC-461 Panel for Carbapenemase Classification and Antimicrobial Susceptibility Testing of <i>Enterobacterales</i>, <i>Pseudomonas aeruginosa</i>, and <i>Acinetobacter</i> spp. [PDF]

Antibiotics (Basel)
Zhang J, Sun L, Zhang G, Kang W, Wang T, Li J, Gao H, Yang Q, Sun K, Wang Q, Sun H.   +10 more
europepmc   +1 more source

Difficult-to-treat resistance (DTR), treatment, and outcomes of carbapenem-resistant Enterobacterales infections in the setting of IMP-type carbapenemase predominance in Japan. [PDF]

Microbiol Spectr
Ohyama K, Uemura K, Matsumura Y, Hase R, Kato H, Matono T, Itoh N, Hashimoto T, Yamamoto G, Mawatari M, Tsutsumi T, Suzuki T, Suzuki M, Hosoda T, Sakurai A, Asai Y, Tsuzuki S, Hayakawa K, van Duin D, Ohmagari N, Doi Y, Saito S.   +21 more
europepmc   +1 more source